Dan Loeb, Third Point Making Moves Last Quarter: Abbott Laboratories (ABT), Electronic Arts Inc. (EA)

Generally speaking, sentiment on this particular segment of healthcare is mixed, though it’s interesting to note that each member of this trio has gained at least 4.5% year-to-date.

At a 4.4% yield, AbbVie pays the highest dividend in S&P 500’s entire healthcare sector, and Abbott offers a much more modest yield of 1.6%. Ariad, meanwhile, is not attractive for income-seeking investors, though Loeb has held the stock since the second quarter of last year. Wall Street’s average price target on Ariad represents an upside of more than 40%, though “monkeys” may be best off by considering all three of these biotech stocks in tandem.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 25.4% between September 2012 and January 2013 versus 7.4% for the S&P 500 index. Try it now by clicking the link above.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!